Physician profile
Jose R Rodriguez Santana
NPI 1013914019
$2,978.02
in general payments reported to CMS, 2019-2025
15 companies · $1,452 in 2025
The $1,452 reported for 2025 was more than what 91% of Pediatric Pulmonology providers received nationally (typical 2025 total: $140).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $474 · 2021: $202 · 2022: $265 · 2023: $435 · 2024: $150 · 2025: $1,452.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,125 · Food and Beverage: $912.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,125.00 |
| Food and Beverage | $912.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $1,277.11 | 2019-2025 | |
| Astrazeneca Pharmaceuticals Lp | $435.46 | 2022-2025 | Tezspire, Fasenra, Breztri |
| Medtronic, INC. | $397.46 | 2023-2025 | Propel, Micra, Maxtack |
| Genzyme Corporation | $128.16 | 2021 | |
| Sobi, INC | $100.00 | 2019 | |
| Glaxosmithkline, LLC. | $100.00 | 2019 | |
| Shire North American Group INC | $97.59 | 2019 | |
| Allergan, INC. | $88.17 | 2019 | |
| United Therapeutics Corporation | $76.55 | 2023 | Tyvaso |
| Biogen, INC. | $73.57 | 2021 | |
| Novartis Pharmaceuticals Corporation | $69.86 | 2022 | |
| Jazz Pharmaceuticals INC. | $62.97 | 2025 | |
| Harmony Biosciences LLC | $27.78 | 2025 | |
| Amgen INC. | $25.00 | 2024 | Tezspire |
| Ani Pharmaceuticals, INC. | $18.34 | 2023 | Purified Cortrophin Gel |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jose Rodriguez Santana listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.